Learn More
Medchemexpress LLC Baricitinib | 1187594-09-7 | C16H17N7O2S | 50 MG

Supplier: Medchemexpress LLC HY15315R50MG
Baricitinib is a selective and orally bioavailable inhibitor of JAK1 and JAK2, widely used in research for its role in epigenetic and JAK/STAT signaling pathways.
- Selective JAK1 and JAK2 inhibitor
- Molecular weight of 371.42
- Inhibits IL-6-stimulated STAT3 phosphorylation
- Prevents IL-23 stimulated production of IL-17 and IL-22 by Th17 cells
- Active in vivo, reducing inflammation and hind paw volumes in animal models
- Stable as a powder for 3 years at -20°C, 2 years at 4°C
- Stable in solvent for 1 year at -80°C, 6 months at -20°C
- Soluble in DMSO (in vitro) and various solutions for in vivo applications
- Solid appearance
- Melting point 212-215°C
- Relative density 1.56 g/cm³
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.